Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine vs. Fluoxetine for Bipolar Depression
NCT02389712Phase 4Terminated
- Sponsor
- Mayo Clinic
- Start
- Mar 2015
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lamotrigine, fluoxetine in bipolar disorder (BD), sponsored by Mayo Clinic. Started Mar 2015; status: terminated.
02
Drugs
lamotriginefluoxetine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02389712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02389712.